INNOVA CAPTAB
|
The Current P/E Ratio of INNOVA CAPTAB is 37.59.
| Share Price | ₹870.3 | May 05,2026 |
| Market Cap | ₹4,977.8 Cr | |
| Earnings-TTM | ₹132.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 37.59x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INNOVA CAPTAB
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,977.8 Cr] as on May 05,2026
(/) Earnings [ ₹132.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 37.59x ]
Thus, for INNOVA CAPTAB , the investors are currently willing to pay 37.59 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INNOVA CAPTAB !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INNOVA CAPTAB over the last five years.
Historical PE (Price/Earnings) ratio chart of INNOVA CAPTAB
PE Ratio Performance Analysis for INNOVA CAPTAB
- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.27x.
- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 39.15x.
- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does INNOVA CAPTAB 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INNOVA CAPTAB | 132.41 | 37.59 | 4,977.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 39.71 | 436,859.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 71.25 | 176,618.0 |
| CIPLA LTD | 4,544.70 | 23.70 | 107,722.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.70 | 144,718.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.26 | 106,081.0 |
| MANKIND PHARMA LTD | 1,796.65 | 53.32 | 95,803.0 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.60 | 91,753.5 |
| LUPIN LTD | 4,669.18 | 22.95 | 107,144.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 23.61 | 82,950.1 |
| ABBOTT INDIA LTD | 1,524.13 | 35.31 | 53,810.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INNOVA CAPTAB 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.60x |
| Max industry PE | 71.25x |
| Median industry PE | 35.31x |
| Average industry PE | 37.18x |
You may also like the below Video Courses